Elanco Animal Health Files 8-K on Shareholder Votes

Ticker: ELAN · Form: 8-K · Filed: 2025-05-21T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

Related Tickers: ELAN

TL;DR

Elanco filed an 8-K on May 21st about shareholder votes from May 16th.

AI Summary

Elanco Animal Health Incorporated filed an 8-K on May 21, 2025, reporting on matters submitted to a vote of security holders as of May 16, 2025. The filing details the company's corporate information, including its principal executive offices in Greenfield, Indiana, and its standard industrial classification as Pharmaceutical Preparations.

Why It Matters

This filing provides transparency regarding important corporate actions and decisions that have been put to a vote by Elanco's shareholders.

Risk Assessment

Risk Level: low — This is a routine filing reporting on shareholder votes, not indicating any immediate financial distress or significant operational changes.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on matters submitted to a vote of Elanco Animal Health Incorporated's security holders.

What is the date of the earliest event reported in this filing?

The date of the earliest event reported in this filing is May 16, 2025.

When was this 8-K report filed?

This 8-K report was filed on May 21, 2025.

Where are Elanco Animal Health Incorporated's principal executive offices located?

Elanco Animal Health Incorporated's principal executive offices are located in Greenfield, Indiana.

What is Elanco Animal Health Incorporated's Standard Industrial Classification code?

Elanco Animal Health Incorporated's Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.

From the Filing

0001104659-25-051136.txt : 20250521 0001104659-25-051136.hdr.sgml : 20250521 20250520184242 ACCESSION NUMBER: 0001104659-25-051136 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250516 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20250521 DATE AS OF CHANGE: 20250520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elanco Animal Health Inc CENTRAL INDEX KEY: 0001739104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 825497352 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38661 FILM NUMBER: 25970461 BUSINESS ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 BUSINESS PHONE: 877-352-6261 MAIL ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 8-K 1 tm2515582d1_8k.htm FORM 8-K false 0001739104 0001739104 2025-05-16 2025-05-16 0001739104 us-gaap:CommonStockMember 2025-05-16 2025-05-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES   SECURITIES AND EXCHANGE COMMISSION Washington , D. C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of Earliest Event Reported): May 16, 2025   Elanco Animal Health Incorporated (Exact name of registrant as specified in its charter)   Indiana   001-38661   82-5497352 (State or other jurisdiction of incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   2500 Innovation Way Greenfield , Indiana (Address of principal executive offices)   46140 (Zip Code)   Registrant’s telephone number, including area code: ( 877 ) 352-6261   Not Applicable (Former Name or Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):   ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common stock, no par value   ELAN   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   ¨   Emerging growth company   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨           Item 5.07 Submission of Matters to a Vote of Security Holders.   Elanco Animal Health Incorporated (the “Company”) held its annual meeting of shareholders on May 16, 2025. Voting results for each matter submitted to a vote at the 2025 annual meeting are provided below.   Proposal 1.  Election of Directors. All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2026 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.   Nomin

View on Read The Filing